High CBLL1 gene (Hakai protein) expression is specifically associated with CMS2 in CRC (the canonical subtype), which is characterized by the activation of WNT, MYC, and EGFR signaling and high expression of cyclins [75]. The gene discussed is MYC; the disease is colorectal carcinoma.